Ucgul Atilgan Cemile, Kosekahya Pinar, Ozkoyuncu Kocabas Dilara, Koc Mustafa, Sakir Goker Yasin
Deparment of Ophthalmology, Ulucanlar Eye Training and Research Hospital, Ankara, Turkey.
Deparment of Ophthalmology, Ulucanlar Eye Training and Research Hospital, Ulucanlar Street Number 59, 06240 Ankara, Turkey.
Ther Adv Ophthalmol. 2020 Aug 27;12:2515841420950857. doi: 10.1177/2515841420950857. eCollection 2020 Jan-Dec.
To evaluate the anatomic changes in the cornea and anterior segment following intravitreal aflibercept loading dose for neovascular age-related macular degeneration.
The study included 40 eyes of 40 patients with neovascular age-related macular degeneration. Each patient underwent a loading dose of one injection per month for three consecutive doses of aflibercept (0.05 ml/2 mg). Before and after the loading dose, a record was made for each patient of corneal topography, anterior segment, corneal densitometry, and lens densitometry parameters with the Pentacam HR and specular microscopy parameters with a non-contact specular microscope. The data before and after the aflibercept loading dose were compared.
Corneal densitometry parameters in the 0- to 2-mm and 2- to 6-mm concentric zones of the posterior layer were significantly higher after the loading dose compared with baseline ( = 0.03, = 0.04, respectively). Corneal densitometry parameters of the anterior, central, and total corneal layer in the 10- to 12-mm concentric zone were also significantly higher after the loading dose compared with baseline ( = 0.009, = 0.02, and = 0.007, respectively). No significant changes were determined in respect of corneal topography, anterior segment, lens densitometry, and specular microscopy parameters ( > 0.05 for all).
The aflibercept loading dose caused slightly increased densitometric values in some corneal regions while it did not affect the corneal topography, anterior segment, lens densitometry, and specular microscopy parameters.
评估玻璃体内注射阿柏西普负荷剂量治疗新生血管性年龄相关性黄斑变性后角膜和眼前节的解剖学变化。
该研究纳入了40例新生血管性年龄相关性黄斑变性患者的40只眼。每位患者每月接受一次负荷剂量注射,连续注射三剂阿柏西普(0.05 ml/2 mg)。在负荷剂量注射前后,使用Pentacam HR为每位患者记录角膜地形图、眼前节、角膜密度测量和晶状体密度测量参数,并使用非接触式角膜内皮显微镜记录角膜内皮显微镜参数。比较阿柏西普负荷剂量注射前后的数据。
与基线相比,负荷剂量注射后后层0至2 mm和2至6 mm同心区域的角膜密度测量参数显著更高(分别为P = 0.03,P = 0.04)。与基线相比,负荷剂量注射后10至12 mm同心区域的角膜前层、中央层和全层角膜密度测量参数也显著更高(分别为P = 0.009,P = 0.02,P = 0.007)。在角膜地形图、眼前节、晶状体密度测量和角膜内皮显微镜参数方面未发现显著变化(所有P>0.05)。
阿柏西普负荷剂量导致某些角膜区域的密度测量值略有增加,而不影响角膜地形图、眼前节、晶状体密度测量和角膜内皮显微镜参数。